Additional file 1: of Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial

Dana Friedrich (4642099)
Hanns-Ulrich Marschall (506679)
Frank Lammert (2875)

Publication date

June 2018

DOI

10.6084/m9.figshare.6444053.v1

Abstract

Table S1. Prevalence of comorbidities in overweight (Nâ=â14) and obese (12) NAFLD patients. In overweight NAFLD subjects, hypercholesterolemia is the dominant concomitant disease. In obese NAFLD patients, arterial hypertension, hyperlipidemia and hyperuricemia are the most common comorbidities. (DOCX 18 kb

Extracted data

We use cookies to provide a better user experience.

Data Protection

Additional file 1: of Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial

Dana Friedrich (4642099)
Hanns-Ulrich Marschall (506679)
Frank Lammert (2875)

Open link

Publication date

June 2018

DOI

10.6084/m9.figshare.6444053.v1

Abstract

Extracted data

Zahra Zare (7011698)
Mahdieh Hosseinzadeh (9279905)
Fatemeh Sharuni (17261632)
Fatemeh Sadat Rohani (17261635)
Hashem Hojjat (17261638)
Shahab Rahimpour (17261641)
Farzan Madadizadeh (9573183)
Javad Zavar Reza (17261644)
Alexei Wong (10188305)
Azadeh Nadjarzadeh (7257014)

October 2023

AimNon-alcoholic fatty liver disease (NAFLD) is a condition characterized by the accumulation of fat...

Additional file 1: of Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis

Borja Hernández-Breijo (3334722)
Chamaida Plasencia-Rodríguez (627498)
Victoria Navarro-Compán (6385358)
Ana Martínez-Feito (6385361)
Andrea Jochems (6385364)
Eva Kneepkens (6385367)
Gerrit Wolbink (6385370)
Theo Rispens (216183)
Cristina Diego (6385373)
Dora Pascual-Salcedo (310351)
Alejandro Balsa (118675)

February 2019

(i) Association between csDMARDs and clinical response (∆ASDAS≥1.1) or remission (ASDAS<1.3) at one ...

Additional file 1: of Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease

Myriam Alexander (5622932)
A. Loomis (5622935)
Jolyon Fairburn-Beech (5622938)
Johan van der Lei (451352)
Talita Duarte-Salles (3499394)
Daniel Prieto-Alhambra (647209)
David Ansell (93210)
Alessandro Pasqua (562256)
Francesco Lapi (494587)
Peter Rijnbeek (3139803)
Mees Mosseveld (505608)
Paul Avillach (173608)
Peter Egger (3139800)
Stuart Kendrick (5622941)
Dawn Waterworth (160856)
Naveed Sattar (8785)
William Alazawi (4672714)

August 2018

Table S1. Characteristics of the primary-care databases included in the study. Figure S1. Identifica...

Additional file 2: of Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial

Dana Friedrich (4642099)
Hanns-Ulrich Marschall (506679)
Frank Lammert (2875)

June 2018

Figure S1. FGF19 serum concentrations at 2 h versus C4 values at 4 h after the oral fat tolerance te...

Additional file 3: of Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial

Dana Friedrich (4642099)
Hanns-Ulrich Marschall (506679)
Frank Lammert (2875)

June 2018

Figure S2. FGF19 serum concentrations at 4 h versus C4 values at 6 h after the oral fat tolerance te...

Additional file 1: of Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): a prospective cohort study

Fang Liu (13271)
Hui Zhou (13228)
Lei Cao (134409)
Zhirong Guo (3344273)
Chen Dong (967)
Lugang Yu (223712)
Yiying Wang (3344264)
Chunxing Liu (3344267)
Jing Qiu (273902)
Yong Xue (307664)
Xingxiang Liu (4440544)
Yunfang Xu (3344270)

September 2018

Table S1. Stratified analysis of NAFLD and platelet count in different subgroup. (DOCX 27 kb

Additional file 1: of Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults

Tilman Kühn (437324)
Tobias Nonnenmacher (5514371)
Disorn Sookthai (3495086)
Ruth Schübel (3397790)
Daniel Quintana Pacheco (5514377)
Oyunbileg von Stackelberg (5514374)
Mirja Graf (5514368)
Theron Johnson (3495092)
Christopher Schlett (5514380)
Romy Kirsten (5514383)
Cornelia Ulrich (3404738)
Rudolf Kaaks (23598)
Hans-Ulrich Kauczor (448631)
Johanna Nattenmüller (3687550)

July 2018

Electronic Supplementary Material: Figure S1. Histogram of MRI-derived liver fat content (%) values....

Additional file 1: of Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study

Xiao Ren (1671724)
Dian Shi (6322961)
Jiao Ding (6322970)
Zhi Cheng (729515)
Hai Li (254910)
Juan Li (146180)
Hong Pu (5449697)
Ai Yang (6322982)
Cai He (2298781)
Jian Zhang (1682)
Yu Ma (111665)
Ya Zhang (7980)
Tong Zheng (113302)
Ya Bai (835303)
Ning Cheng (483330)

February 2019

Table S1. Relative Risk of some factors in normal and NAFLD groups. Table S2. Variable scoring list ...

Additional file 2: of Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults

Jing Luo (146659)
Qian Chen (18883)
Tianran Shen (1568260)
Xu Wang (28596)
Wanjun Fang (5948006)
Xiaocai Wu (5948009)
Zenan Yuan (5948012)
Gengdong Chen (5948015)
Wenhua Ling (163611)
Yuming Chen (108442)

November 2018

Table S2. Association of serum SHBG levels with metabolic risk factors using multiple linear regress...

Additional file 1: of Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis

Ke Pu (2556748)
Yuping Wang (35936)
Suyang Bai (5351927)
Hui Wei (126971)
Yongning Zhou (1699492)
Jiangao Fan (6565982)
Liang Qiao (34983)

April 2019

Figure S1. Diagnostic odds ratio (DOR) of CAP for steatosis in suspected NAFLD patients. Figure S2. ...

Additional file 1: Table S1. of The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease

Shujun Zhang (314599)
Tingting Du (9414)
Jianhua Zhang (6347)
Huiming Lu (39961)
Xuan Lin (1716175)
Junhui Xie (3682897)
Yan Yang (33204)
Xuefeng Yu (329731)

January 2017

Odds ratios for NAFLD in different quartiles of TyG index or ALT in ALT <40 and âĽ40 U/L groups. Ta...

Additional file 1: of Non-HDL-cholesterol to HDL-cholesterol ratio is an independent risk factor for liver function tests abnormalities in geriatric population

Tianhui An (6163568)
Yi Song (105202)
Yi Yang (116183)
Mengyuan Guo (1814593)
Hui Liu (33624)
Kun Liu (148201)
Zhaohui Wang (144332)

December 2018

Figure S1. The portion of chronic LFTs abnormalities and NAFLD patients according to Non-HDL/ HDL le...

Additional file 1: of Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation

Jiahua Fan (6249098)
Yangqing Liu (289844)
Songping Yin (6249101)
Nixuan Chen (6249104)
Xinxiu Bai (6249110)
Qiuyi Ke (6249113)
Jia Shen (1828945)
Min Xia (307622)

January 2019

Figure S1. The relationship between sdLDL-c/LDL-c ratio and prevalence of MetS. Table S1. Logistic r...

Additional file 2: of Non-HDL-cholesterol to HDL-cholesterol ratio is an independent risk factor for liver function tests abnormalities in geriatric population

Tianhui An (6163568)
Yi Song (105202)
Yi Yang (116183)
Mengyuan Guo (1814593)
Hui Liu (33624)
Kun Liu (148201)
Zhaohui Wang (144332)

December 2018

Figure S2. The portion of NAFLD patients according to Non-HDL/ HDL levels tertiles. The cut of value...

Additional file 2 of Association between serum uric acid-to-creatinine ratio and non-alcoholic fatty liver disease: a cross-sectional study in Chinese non-obese people with a normal range of low-density lipoprotein cholesterol

Xiaoyu Wang (182979)
Yong Han (111920)
Yufei Liu (796612)
Haofei Hu (8534712)

September 2022

Additional file 2. Table S1. The results of univariate analysis. Table S2. The characteristics of pa...

Zahra Zare (7011698)
Mahdieh Hosseinzadeh (9279905)
Fatemeh Sharuni (17261632)
Fatemeh Sadat Rohani (17261635)
Hashem Hojjat (17261638)
Shahab Rahimpour (17261641)
Farzan Madadizadeh (9573183)
Javad Zavar Reza (17261644)
Alexei Wong (10188305)
Azadeh Nadjarzadeh (7257014)

October 2023

AimNon-alcoholic fatty liver disease (NAFLD) is a condition characterized by the accumulation of fat...

Additional file 1: of Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis

Borja Hernández-Breijo (3334722)
Chamaida Plasencia-Rodríguez (627498)
Victoria Navarro-Compán (6385358)
Ana Martínez-Feito (6385361)
Andrea Jochems (6385364)
Eva Kneepkens (6385367)
Gerrit Wolbink (6385370)
Theo Rispens (216183)
Cristina Diego (6385373)
Dora Pascual-Salcedo (310351)
Alejandro Balsa (118675)

February 2019

(i) Association between csDMARDs and clinical response (∆ASDAS≥1.1) or remission (ASDAS<1.3) at one ...

Additional file 1: of Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease

Myriam Alexander (5622932)
A. Loomis (5622935)
Jolyon Fairburn-Beech (5622938)
Johan van der Lei (451352)
Talita Duarte-Salles (3499394)
Daniel Prieto-Alhambra (647209)
David Ansell (93210)
Alessandro Pasqua (562256)
Francesco Lapi (494587)
Peter Rijnbeek (3139803)
Mees Mosseveld (505608)
Paul Avillach (173608)
Peter Egger (3139800)
Stuart Kendrick (5622941)
Dawn Waterworth (160856)
Naveed Sattar (8785)
William Alazawi (4672714)

August 2018

Table S1. Characteristics of the primary-care databases included in the study. Figure S1. Identifica...

Dana Friedrich (4642099)
Hanns-Ulrich Marschall (506679)
Frank Lammert (2875)

June 2018

Figure S1. FGF19 serum concentrations at 2 h versus C4 values at 4 h after the oral fat tolerance te...

Dana Friedrich (4642099)
Hanns-Ulrich Marschall (506679)
Frank Lammert (2875)

June 2018

Figure S2. FGF19 serum concentrations at 4 h versus C4 values at 6 h after the oral fat tolerance te...

Additional file 1: of Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): a prospective cohort study

Fang Liu (13271)
Hui Zhou (13228)
Lei Cao (134409)
Zhirong Guo (3344273)
Chen Dong (967)
Lugang Yu (223712)
Yiying Wang (3344264)
Chunxing Liu (3344267)
Jing Qiu (273902)
Yong Xue (307664)
Xingxiang Liu (4440544)
Yunfang Xu (3344270)

September 2018

Table S1. Stratified analysis of NAFLD and platelet count in different subgroup. (DOCX 27 kb

Additional file 1: of Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults

Tilman Kühn (437324)
Tobias Nonnenmacher (5514371)
Disorn Sookthai (3495086)
Ruth Schübel (3397790)
Daniel Quintana Pacheco (5514377)
Oyunbileg von Stackelberg (5514374)
Mirja Graf (5514368)
Theron Johnson (3495092)
Christopher Schlett (5514380)
Romy Kirsten (5514383)
Cornelia Ulrich (3404738)
Rudolf Kaaks (23598)
Hans-Ulrich Kauczor (448631)
Johanna Nattenmüller (3687550)

July 2018

Electronic Supplementary Material: Figure S1. Histogram of MRI-derived liver fat content (%) values....

Additional file 1: of Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study

Xiao Ren (1671724)
Dian Shi (6322961)
Jiao Ding (6322970)
Zhi Cheng (729515)
Hai Li (254910)
Juan Li (146180)
Hong Pu (5449697)
Ai Yang (6322982)
Cai He (2298781)
Jian Zhang (1682)
Yu Ma (111665)
Ya Zhang (7980)
Tong Zheng (113302)
Ya Bai (835303)
Ning Cheng (483330)

February 2019

Table S1. Relative Risk of some factors in normal and NAFLD groups. Table S2. Variable scoring list ...

Additional file 2: of Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults

Jing Luo (146659)
Qian Chen (18883)
Tianran Shen (1568260)
Xu Wang (28596)
Wanjun Fang (5948006)
Xiaocai Wu (5948009)
Zenan Yuan (5948012)
Gengdong Chen (5948015)
Wenhua Ling (163611)
Yuming Chen (108442)

November 2018

Table S2. Association of serum SHBG levels with metabolic risk factors using multiple linear regress...

Ke Pu (2556748)
Yuping Wang (35936)
Suyang Bai (5351927)
Hui Wei (126971)
Yongning Zhou (1699492)
Jiangao Fan (6565982)
Liang Qiao (34983)

April 2019

Figure S1. Diagnostic odds ratio (DOR) of CAP for steatosis in suspected NAFLD patients. Figure S2. ...

Additional file 1: Table S1. of The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease

Shujun Zhang (314599)
Tingting Du (9414)
Jianhua Zhang (6347)
Huiming Lu (39961)
Xuan Lin (1716175)
Junhui Xie (3682897)
Yan Yang (33204)
Xuefeng Yu (329731)

January 2017

Odds ratios for NAFLD in different quartiles of TyG index or ALT in ALT <40 and âĽ40 U/L groups. Ta...

Additional file 1: of Non-HDL-cholesterol to HDL-cholesterol ratio is an independent risk factor for liver function tests abnormalities in geriatric population

Tianhui An (6163568)
Yi Song (105202)
Yi Yang (116183)
Mengyuan Guo (1814593)
Hui Liu (33624)
Kun Liu (148201)
Zhaohui Wang (144332)

December 2018

Figure S1. The portion of chronic LFTs abnormalities and NAFLD patients according to Non-HDL/ HDL le...

Additional file 1: of Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation

Jiahua Fan (6249098)
Yangqing Liu (289844)
Songping Yin (6249101)
Nixuan Chen (6249104)
Xinxiu Bai (6249110)
Qiuyi Ke (6249113)
Jia Shen (1828945)
Min Xia (307622)

January 2019

Figure S1. The relationship between sdLDL-c/LDL-c ratio and prevalence of MetS. Table S1. Logistic r...

Additional file 2: of Non-HDL-cholesterol to HDL-cholesterol ratio is an independent risk factor for liver function tests abnormalities in geriatric population

Tianhui An (6163568)
Yi Song (105202)
Yi Yang (116183)
Mengyuan Guo (1814593)
Hui Liu (33624)
Kun Liu (148201)
Zhaohui Wang (144332)

December 2018

Figure S2. The portion of NAFLD patients according to Non-HDL/ HDL levels tertiles. The cut of value...

Xiaoyu Wang (182979)
Yong Han (111920)
Yufei Liu (796612)
Haofei Hu (8534712)

September 2022

Additional file 2. Table S1. The results of univariate analysis. Table S2. The characteristics of pa...

Zahra Zare (7011698)
Mahdieh Hosseinzadeh (9279905)
Fatemeh Sharuni (17261632)
Fatemeh Sadat Rohani (17261635)
Hashem Hojjat (17261638)
Shahab Rahimpour (17261641)
Farzan Madadizadeh (9573183)
Javad Zavar Reza (17261644)
Alexei Wong (10188305)
Azadeh Nadjarzadeh (7257014)

October 2023

AimNon-alcoholic fatty liver disease (NAFLD) is a condition characterized by the accumulation of fat...

Additional file 1: of Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis

Borja Hernández-Breijo (3334722)
Chamaida Plasencia-Rodríguez (627498)
Victoria Navarro-Compán (6385358)
Ana Martínez-Feito (6385361)
Andrea Jochems (6385364)
Eva Kneepkens (6385367)
Gerrit Wolbink (6385370)
Theo Rispens (216183)
Cristina Diego (6385373)
Dora Pascual-Salcedo (310351)
Alejandro Balsa (118675)

February 2019

(i) Association between csDMARDs and clinical response (∆ASDAS≥1.1) or remission (ASDAS<1.3) at one ...

Additional file 1: of Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease

Myriam Alexander (5622932)
A. Loomis (5622935)
Jolyon Fairburn-Beech (5622938)
Johan van der Lei (451352)
Talita Duarte-Salles (3499394)
Daniel Prieto-Alhambra (647209)
David Ansell (93210)
Alessandro Pasqua (562256)
Francesco Lapi (494587)
Peter Rijnbeek (3139803)
Mees Mosseveld (505608)
Paul Avillach (173608)
Peter Egger (3139800)
Stuart Kendrick (5622941)
Dawn Waterworth (160856)
Naveed Sattar (8785)
William Alazawi (4672714)

August 2018

Table S1. Characteristics of the primary-care databases included in the study. Figure S1. Identifica...

Additional file 1: of Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial

Abstract

Extracted data

Additional file 1: of Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial

Abstract

Extracted data

Related items

Related items